GDF15 Knockdown Suppresses Cervical Cancer Cell Migration In vitro Through the TGF-β/Smad2/3/Snail1 Pathway

Overview

Journal FEBS Open Bio

Specialty Biology

Date 2020 Oct 24

PMID 33098235

Citations 15

Authors

Li Li

Ruihong Zhang

Hailei Yang

Donghua Zhang

Jiwei Liu

Jinfang Li

Bin Guo

Affiliations

Soon will be listed here.

Abstract

Growth differentiation factor 15 (GDF15), a member of the transforming growth factor β (TGF-β) superfamily, is a prognostic biomarker of cervical cancer. In addition, GDF15 has been reported to enhance the migration of colorectal cancer cells and liver cancer stem-like cells. However, the mechanism by which GDF15 promotes cervical cancer cell migration is not completely understood. Here, we report that GDF15 expression is enhanced in cervical cancer tissues, as well as in cultured cervical cancer cells. ShGDF15 transfection markedly inhibited expression of Vimentin, N-cadherin and Snail1, and resulted in up-regulation of E-cadherin expression in HT-3 and HeLa cells. Moreover, knockdown of GDF15 suppressed wound healing rate and reduced the number of invasive cells. Furthermore, knockdown of GDF15 significantly suppressed the expression of phosphorylated Smad2 and Smad3. The addition of TGF-β1 partially abolished the inhibitory effects of GDF15 knockdown on the migration and invasion of cervical cancer cells. In summary, we report here that GDF15 knockdown inhibits migration and invasion of cervical cancer cells in vitro through the TGF-β/Smad2/3/Snail1 pathway.

Citing Articles

Exploration of key pathogenic mechanisms and potential intervention targets of the traditional Chinese medicine Coptis chinensis in the treatment of cervical cancer based on network pharmacology and molecular docking techniques.

Hou Y, Zhang L, Li H, Zhang R, Sun J, Jia H Transl Cancer Res. 2025; 14(1):626-639.

PMID: 39974420 PMC: 11833389. DOI: 10.21037/tcr-2024-2608.

GDF15/MIC-1: a stress-induced immunosuppressive factor which promotes the aging process.

Salminen A Biogerontology. 2024; 26(1):19.

PMID: 39643709 PMC: 11624233. DOI: 10.1007/s10522-024-10164-0.

Circ_0008035 Promotes Gastric Cancer Development via the miR-429/SMAD2 Cascade.

Chen Y, Bian W, Chen S Turk J Gastroenterol. 2024; 35(10):795-804.

PMID: 39412408 PMC: 11465158. DOI: 10.5152/tjg.2024.23341.

Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma.

Yang D, He Z, Lu J, Yuan X, Liu H, Xue Y Cell Div. 2023; 18(1):21.

PMID: 38082448 PMC: 10712134. DOI: 10.1186/s13008-023-00103-9.

Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway.

Chen P, Liao Y, Cheng Y, Wu H, Wu Y, Huang M Oncogenesis. 2023; 12(1):49.

PMID: 37907465 PMC: 10618527. DOI: 10.1038/s41389-023-00494-y.

References

Wan F, Miao X, Quraishi I, Kennedy V, Creek K, Pirisi L . Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int J Cancer. 2008; 123(1):32-40. PMC: 2872618. DOI: 10.1002/ijc.23463. View

Li S, Ma Y, Zheng P, Zhang P . GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. J Exp Clin Cancer Res. 2018; 37(1):80. PMC: 5894198. DOI: 10.1186/s13046-018-0744-0. View

Kalli M, Minia A, Pliaka V, Fotis C, Alexopoulos L, Stylianopoulos T . Solid stress-induced migration is mediated by GDF15 through Akt pathway activation in pancreatic cancer cells. Sci Rep. 2019; 9(1):978. PMC: 6353927. DOI: 10.1038/s41598-018-37425-6. View

Yin R, Hao D, Chen P . Expression and correlation of MMP-9, VEGF, and p16 in infantile hemangioma. Eur Rev Med Pharmacol Sci. 2018; 22(15):4806-4811. DOI: 10.26355/eurrev_201808_15615. View

Emmerson P, Wang F, Du Y, Liu Q, Pickard R, Gonciarz M . The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017; 23(10):1215-1219. DOI: 10.1038/nm.4393. View

Lamouille S, Xu J, Derynck R . Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15(3):178-96. PMC: 4240281. DOI: 10.1038/nrm3758. View

Zhang W, Hu C, Wang X, Bai S, Cao S, Kobelski M . Role of GDF15 in methylseleninic acid-mediated inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. PLoS One. 2019; 14(9):e0222812. PMC: 6754141. DOI: 10.1371/journal.pone.0222812. View

Baek S, Eling T . Growth differentiation factor 15 (GDF15): A survival protein with therapeutic potential in metabolic diseases. Pharmacol Ther. 2019; 198:46-58. PMC: 7196666. DOI: 10.1016/j.pharmthera.2019.02.008. View

Chen T, You Y, Jiang H, Wang Z . Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 2017; 232(12):3261-3272. PMC: 5507753. DOI: 10.1002/jcp.25797. View

10.

Basil C, Zhao Y, Zavaglia K, Jin P, Panelli M, Voiculescu S . Common cancer biomarkers. Cancer Res. 2006; 66(6):2953-61. DOI: 10.1158/0008-5472.CAN-05-3433. View

11.

Liu D, Guo H, Li Y, Xu X, Yang K, Bai Y . Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS One. 2012; 7(2):e31251. PMC: 3279370. DOI: 10.1371/journal.pone.0031251. View

12.

Hui P, Xu X, Xu L, Hui G, Wu S, Lan Q . Expression of MMP14 in invasive pituitary adenomas: relationship to invasion and angiogenesis. Int J Clin Exp Pathol. 2015; 8(4):3556-67. PMC: 4466925. View

13.

Emmerson P, Duffin K, Chintharlapalli S, Wu X . GDF15 and Growth Control. Front Physiol. 2018; 9:1712. PMC: 6277789. DOI: 10.3389/fphys.2018.01712. View

14.

Sasahara A, Tominaga K, Nishimura T, Yano M, Kiyokawa E, Noguchi M . An autocrine/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells. Oncotarget. 2017; 8(15):24869-24881. PMC: 5421895. DOI: 10.18632/oncotarget.15276. View

15.

Zhang Y, Jiang M, Nouraie M, Roth M, Tabib T, Winters S . GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2019; 317(4):L510-L521. PMC: 6842909. DOI: 10.1152/ajplung.00062.2019. View

16.

Eling T, Baek S, Shim M, Lee C . NSAID activated gene (NAG-1), a modulator of tumorigenesis. J Biochem Mol Biol. 2006; 39(6):649-55. DOI: 10.5483/bmbrep.2006.39.6.649. View

17.

Li C, Wang J, Kong J, Tang J, Wu Y, Xu E . GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget. 2015; 7(1):860-72. PMC: 4808038. DOI: 10.18632/oncotarget.6205. View

18.

Fang J, Zhang H, Jin S . Epigenetics and cervical cancer: from pathogenesis to therapy. Tumour Biol. 2014; 35(6):5083-93. DOI: 10.1007/s13277-014-1737-z. View

19.

Chen G, Wang M, Liu X . GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway. Mol Med Rep. 2019; 20(5):4262-4270. DOI: 10.3892/mmr.2019.10664. View

20.

Moustakas A, Heldin C . Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007; 98(10):1512-20. PMC: 11158989. DOI: 10.1111/j.1349-7006.2007.00550.x. View